REVIEW OF THE CARDIOVASCULAR ADVERSITY OF THE CALCIUM-ANTAGONIST BETA-BLOCKER COMBINATION - IMPLICATIONS FOR ANTIHYPERTENSIVE THERAPY

被引：28
作者：
BROUWER, RML
FOLLATH, F
BUHLER, FR
机构：
[1] UNIV HOSP BASEL, KANTONSSPITAL, DIV CARDIOL, CH-4031 BASEL, SWITZERLAND
[2] UNIV HOSP BASEL, DIV CLIN PHARMACOL, CH-4031 BASEL, SWITZERLAND
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1985年 / 7卷
关键词：
D O I：
10.1097/00005344-198507004-00008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S38 / S44
页数：7
相关论文
共 69 条
[41]  
LESSEM J, 1982, ACTA MED SCAND, V681, P83
[42]  
LESSEM J, 1981, CALCIUM ANTAGONISTS, pS159
[43]  
LEWIS GRJ, 1978, NEW ZEAL MED J, V87, P351
[44]   THE EFFECTS OF CALCIUM-CHANNEL BLOCKING-AGENTS ON CARDIOVASCULAR FUNCTION [J].
LOW, RI ;
TAKEDA, P ;
MASON, DT ;
DEMARIA, AN .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (03) :547-553
[45]  
MCGOURTY JC, 1984, BR J CLIN PHARM, V17, pP683
[46]  
MCINNES G, 1984, CALCIUM ANTAGONISTS, V62, P69
[47]  
MIDTBO K, 1980, CURR THER RES CLIN E, V27, P830
[48]   COMPARATIVE CLINICAL ELECTROPHYSIOLOGIC EFFECTS OF DILTIAZEM, VERAPAMIL AND NIFEDIPINE - A REVIEW [J].
MITCHELL, LB ;
SCHROEDER, JS ;
MASON, JW .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (03) :629-635
[49]   USE OF PROTEIN-A BEARING STAPHYLOCOCCUS-AUREUS IN ENZYME-IMMUNOASSAY (EIA) [J].
MOTTOLESE, M ;
IACONA, A ;
NATALI, PG .
IMMUNOLOGICAL COMMUNICATIONS, 1980, 9 (04) :379-387
[50]   ROLE OF NIFEDIPINE IN TREATMENT OF HYPERTENSION [J].
MURPHY, MB ;
SCRIVEN, AJI ;
DOLLERY, CT .
BRITISH MEDICAL JOURNAL, 1983, 287 (6387) :257-259
1234567